Rocket Pharmaceuticals, Inc.
RCKT
$3.47
$0.133.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 278.78% | 22.40% | 29.49% | 24.56% | 1.04% |
| Total Depreciation and Amortization | -18.46% | -28.20% | -6.10% | 35.62% | 8.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,082.81% | -9.48% | -46.41% | -12.21% | 39.26% |
| Change in Net Operating Assets | -25.74% | -30.14% | -83.19% | -491.81% | 20.53% |
| Cash from Operations | 19.10% | 18.63% | 25.78% | 3.23% | 9.03% |
| Capital Expenditure | 84.00% | 74.45% | 74.11% | 103.40% | 97.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 573.88% | 130.42% | 197.19% | 16.22% | -44.73% |
| Cash from Investing | 574.92% | 130.06% | 196.18% | 18.62% | -42.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -30.23% | -- | -100.00% | -138.07% | -85.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,129.53% | 75.45% | -98.38% | 59.78% | -610.00% |